Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Dermatol ; 175(5): 1049-1051, 2016 Nov.
Article in English | MEDLINE | ID: mdl-26992073

ABSTRACT

We present two cases of patients with systemic autoimmune diseases (one with dermatomyositis and one with CREST syndrome) who presented with a worsening of calcinosis cutis after treatment of osteoporosis with teriparatide. To our knowledge, this association is not described in the literature and might be considered in the spectrum of adverse reactions to teriparatide.


Subject(s)
Bone Density Conservation Agents/adverse effects , Calcinosis/chemically induced , Osteoporosis/drug therapy , Skin Diseases/chemically induced , Teriparatide/adverse effects , Aged , CREST Syndrome/complications , Dermatomyositis/complications , Female , Humans , Middle Aged , Osteoporosis/complications
2.
Int J Neurosci ; 125(12): 936-40, 2015.
Article in English | MEDLINE | ID: mdl-25350870

ABSTRACT

Tumor Necrosis Factor-alpha (TNF-α) is an immunomodulatory and proinflammatory cytokine implicated in neuro-inflammation and neuronal damage in response to cerebral ischemia. The present study tested the hypothesis that anti-TNF-α agents may be protective against cerebral infarction. Transient focal ischemia was artificially induced in anesthetized adult male Wistar rats (300-350 g) by middle cerebral artery occlusion (MCAO) with an intraluminal suture. TNF-α function was interfered with either a chimeric monoclonal antibody against TNF-α (infliximab-7 mg/kg) aiming to TNF-α soluble and membrane-attached form; or a chimeric fusion protein of TNF-α receptor-2 with a fragment crystallizable (Fc) region of IgG1 (etanercept-5 mg/kg) aiming for the TNF-α soluble form. Both agents were administered intraperitoneally 0 or 6 h after inducing ischemia. Infarct volume was measured by 2,3,5-triphenyltetrazolium chloride staining. Cerebral infarct volume was significantly reduced in either etanercept or infliximab-treated group compared with non-treated MCAO rats 24 h after reperfusion. These results suggest that anti-TNF-α agents may reduce focal ischemic injury in rats.


Subject(s)
Brain Injuries/prevention & control , Etanercept/therapeutic use , Infliximab/therapeutic use , Neuroprotective Agents/therapeutic use , Tumor Necrosis Factor-alpha/metabolism , Animals , Brain Infarction/etiology , Brain Infarction/prevention & control , Brain Injuries/etiology , Disease Models, Animal , Infarction, Middle Cerebral Artery/complications , Infarction, Middle Cerebral Artery/drug therapy , Male , Rats , Rats, Wistar , Time Factors , Tumor Necrosis Factor-alpha/immunology
3.
Rheumatol Int ; 34(5): 723-5, 2014 May.
Article in English | MEDLINE | ID: mdl-23292188

ABSTRACT

We report an adult female patient with Takayasu arteritis (TA) receiving conventional medical treatment and anti-TNF therapy, which developed progressive thoracic and abdominal aortic aneurysms. She developed imminent rupture of the thoracic aneurysm and an endovascular stent-graft (EVSG) was emergency implanted and a year after this procedure the abdominal aneurysm increased in size requiring reoperation and placement of another EVSG. Both procedures had a very good outcome. This case shows the effectivity and security of multiple EVSG implantations in multiple aortic aneurisms in patients with TA.


Subject(s)
Aortic Aneurysm, Abdominal/surgery , Aortic Aneurysm, Thoracic/surgery , Blood Vessel Prosthesis Implantation/instrumentation , Blood Vessel Prosthesis , Endovascular Procedures/instrumentation , Stents , Takayasu Arteritis/complications , Takayasu Arteritis/drug therapy , Adult , Aortic Aneurysm, Abdominal/diagnosis , Aortic Aneurysm, Abdominal/etiology , Aortic Aneurysm, Thoracic/diagnosis , Aortic Aneurysm, Thoracic/etiology , Aortography/methods , Biological Products/therapeutic use , Female , Humans , Reoperation , Takayasu Arteritis/diagnosis , Takayasu Arteritis/immunology , Tomography, X-Ray Computed , Treatment Outcome , Tumor Necrosis Factor-alpha/antagonists & inhibitors
4.
Rheumatol Int ; 32(2): 541-3, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21267573

ABSTRACT

Relapsing polychondritis (RP) is an autoimmune disease characterized by inflammation and destruction of all type of body cartilage, and the cartilage trauma may be a trigger of the disease in a susceptible person. We describe the clinical and laboratory findings in a group of 18 patients with RP with (7 cases) or without (11 cases) anteceding cartilage trauma. The mean age was 41 years in the group with cartilage trauma and 55 years in the group without cartilage trauma. For both groups, female gender was predominant. All patients presented with auricular chondritis. Systemic manifestations and autoimmunity were more common in patients with anteceding trauma.


Subject(s)
Autoimmune Diseases/diagnosis , Cartilage/immunology , Cartilage/injuries , Polychondritis, Relapsing/diagnosis , Wounds and Injuries/diagnosis , Adult , Aged , Aged, 80 and over , Autoimmune Diseases/epidemiology , Cartilage/pathology , Comorbidity/trends , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Polychondritis, Relapsing/epidemiology , Polychondritis, Relapsing/immunology , Retrospective Studies , Wounds and Injuries/epidemiology , Wounds and Injuries/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...